Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron

Cited by (959)

Items 601–700 of 959

  1. Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members
    Andrew W. Hwang, Hanna Trzeciakiewicz, Dave Friedmann, Chao‐Xing Yuan, Ronen Marmorstein, Virginia M.‐Y. Lee, Todd J. Cohen · 2016 · PLoS ONE
  2. Screening of a neuronal cell model of tau pathology for therapeutic compounds
    Marcus Pickhardt, Michele Tassoni, Philip Denner, Birgit Kurkowsky, Ana Kitanovic, Christoph Möhl, Eugenio Fava, Eckhard Mandelkow� · 2018 · Neurobiology of Aging
  3. Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders
    Ramón Cacabelos, Pablo Cacabelos, Juan C. Carril · 2019 · Elsevier eBooks
  4. Protective effects of a small-molecule inhibitor DDQ against tau-induced toxicities in a transgenic tau mouse model of Alzheimer’s disease
    Murali Vijayan, Mathew George, Lloyd E. Bunquin, Chhanda Bose, P. Hemachandra Reddy · 2021 · Human Molecular Genetics
  5. Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions
    Bidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, Aradhana Prajapati · 2022 · Neurotoxicity Research
  6. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease
    Chrisostomos Prodromou, Xavier Aran-Guiu, Jasmeen Oberoi, Laura Perna, J. Paul Chapple, Jacqueline van der Spuy · 2022 · Sub-cellular biochemistry/Subcellular biochemistry
  7. 24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1/PGC1α/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer’s Disease
    Gabriella Testa, Serena Giannelli, Barbara Sottero, Erica Staurenghi, Giorgio Giaccone, Paola Caroppo, Paola Gamba, Gabriella Leonarduzzi · 2023 · Antioxidants
  8. Dysregulation of histone deacetylases in ocular diseases
    Jae Hyun Jun, Jun-Sik Kim, Leon F. Palomera, Dong‐Gyu Jo · 2023 · Archives of Pharmacal Research
  9. The emerging role of exercise in Alzheimer’s disease: Focus on mitochondrial function
    Lili Feng, Bowen Li, Su Sean Yong, Wen Xu, Zhenjun Tian · 2024 · Ageing Research Reviews
  10. RETRACTED: Sanhua Decoction, a Classic Herbal Prescription, Exerts Neuroprotection Through Regulating Phosphorylated Tau Level and Promoting Adult Endogenous Neurogenesis After Cerebral Ischemia/Reperfusion Injury
    Deng-lei Fu, Ji-huang Li, Yi‐Hua Shi, Xi-Le Zhang, Yan Lin, Guo‐qing Zheng · 2020 · Frontiers in Physiology · Retracted
  11. Effects of Aerobic Exercise on Tau and Related Proteins in Rats with the Middle Cerebral Artery Occlusion
    Sakulrat Mankhong, Sujin Kim, Sohee Moon, Kyoung‐Hee Lee, Hyeong-Eun Jeon, Byeong-Hun Hwang, Jong-Won Beak, Kyung‐Lim Joa, Ju‐Hee Kang · 2020 · International Journal of Molecular Sciences
  12. Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects
    Hadeel Alyenbaawi, W. Ted Allison, Sue‐Ann Mok · 2020 · Biomolecules
  13. Acetylation Unleashes Protein Demons of Dementia
    Mark P. Mattson · 2010 · Neuron
  14. Sleep and Alzheimer: The Link
    Archana Gaur T, Ariyanachi Kaliappan, Yuvaraj Balan, Varatharajan Sakthivadivel, Kalpana Medala, Madhusudhan Umesh · 2022 · MAEDICA – a Journal of Clinical Medicine
  15. Oxidation and ubiquitination in neurodegeneration
    Beat Michel Riederer, Geneviève Leuba, Zeinab ElHajj · 2013 · Experimental Biology and Medicine
  16. Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies
    Davidson, Ryder, Krider, Reese I., Borsellino, Philip, Noorda, Keith, Alhwayek, George, Vida, Thomas A. · 2023 · Current Issues in Molecular Biology
  17. Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats
    Yu Feng Zou, Lulu Guan, Jingwang Tan, Bote Qi, Yunxiang Sun, Fengjuan Huang, Qingwen Zhang · 2024 · Journal of Chemical Information and Modeling
  18. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer’s Disease Brain
    Stefani N. Thomas, Austin J. Yang · 2016 · Methods in molecular biology
  19. Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice
    Xin Wang, En-Jie Liu, Qian Rong Liu, Shihong Li, Ting Li, Qiuzhi Zhou, Yanchao Liu, Huaqiu Zhang, Jian‐Zhi Wang · 2020 · Journal of Alzheimer s Disease
  20. Cytoskeleton saga: Its regulation in normal physiology and modulation in neurodegenerative disorders
    Santimoy Sen, Sheetal Lagas, Abhishek Roy, Hemant Kumar · 2022 · European Journal of Pharmacology
  21. Regulation of Tau Homeostasis and Toxicity by Acetylation
    Tara E. Tracy, Kathryn C. Claiborn, Li Gan · 2019 · Advances in experimental medicine and biology
  22. Aromatic Ring Fluorination Patterns Modulate Inhibitory Potency of Fluorophenylhydroxamates Complexed with Histone Deacetylase 6
    Paris R. Watson, Ping Bai, Changning Wang, Abigail D. Cragin, Jacob M. Hooker, David W. Christianson · 2022 · Biochemistry
  23. Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases
    Jafar Sadeghzadeh, Parviz Shahabi, Mehdi Farhoudi, Abbas Ebrahimi Kalan, Ahmad Mobed, Kourosh Shahpasand · 2022 · Advanced Pharmaceutical Bulletin
  24. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease
    Pei-Pei Guan, Pu Wang · 2023 · Molecular Neurobiology
  25. Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease
    Tanvir Ahmed · 2024 · European Journal of Neuroscience
  26. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
    Elise E. Dunning, Boris Decourt, Nasser H. Zawia, Holly A. Shill, Marwan Noel Sabbagh · 2024 · Neurology and Therapy
  27. Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation
    Qi Xu, Dan Liu, Ling‐Qiang Zhu, Ying Su, He‐Zhou Huang · 2025 · Alzheimer s & Dementia
  28. Sirtuins and Proteolytic Systems: Implications for Pathogenesis of Synucleinopathies
    Belém Sampaio‐Marques, Paula Ludovico · 2015 · Biomolecules
  29. From Small Peptides to Large Proteins against Alzheimer’sDisease
    Pasquale Picone, Tiziana Sanfilippo, Sonya Vasto, Sara Baldassano, Rossella Guggino, Domenico Nuzzo, Donatella Bulone, Pier Luigi San Biagio, Emanuela Muscolino, Roberto Monastero et al. · 2022 · Biomolecules
  30. Tau and neuron aging.
    Jesús Ávila, Elena Gómez de Barreda, Noemí Pallas‐Bazarra, Félix Hernández · 2013 · Europe PMC (PubMed Central)
  31. SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion
    Xiaomin Yin, Xiaosu Jiang, Jia Wang, Shuo Qian, Fei Liu, Wei Qian · 2017 · Journal of Alzheimer s Disease
  32. SIRT1 Regulates Tau Expression and Tau Synaptic Pathology
    Xiaomin Yin, Zheng Zhou, Yanyan Qiu, Xing Fan, Chenhao Zhao, Junze Bao, Chenxu Liu, Fei Liu, Wei Qian · 2021 · Journal of Alzheimer s Disease
  33. The tau oligomer antibody APNmAb005 detects early-stage pathological tau enriched at synapses and rescues neuronal loss in long-term treatments
    Hwan‐Ching Tai, Haou-Tzong Ma, Shien-Chieh Huang, Meng‐Fang Wu, Chia‐Lin Wu, Yen‐Ting Lai, Zhong‐Lin Li, Richard A. Margolin, Anthony J. Intorcia, Geidy E. Serrano et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
    Paulo J. da Costa, Malika Hamdane, Luc Buée, Franck Martin · 2022 · Biomedicines
  35. Palmitic Acid Induces Posttranslational Modifications of Tau Protein in Alzheimer’s Disease–Related Epitopes and Increases Intraneuronal Tau Levels
    Valeria Melissa García-Cruz, Clorinda Arias · 2024 · Molecular Neurobiology
  36. Amyloid-β (25–35) regulates neuronal damage and memory loss via SIRT1/Nrf2 in the cortex of mice
    Lin Zhu, Fangjin Lu, Xiaoyu Jia, Qiuying Yan, Xiaoran Zhang, Ping Mu · 2021 · Journal of Chemical Neuroanatomy
  37. Time-course miRNA alterations and SIRT1 inhibition triggered by adolescent lead exposure in mice
    Rundong Liu, Yawei Wang, Lin Bai, Ruike Wang, Yingying Wu, Mengchen Liu, Qiong Li, Yue Ba, Huizhen Zhang, Guoyu Zhou et al. · 2021 · Toxicology Research
  38. Aging-Related Tau Astrogliopathy in Aging and Neurodegeneration
    Heather McCann, Briony Durand, Claire E. Shepherd · 2021 · Brain Sciences
  39. Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice
    Sungsu Lim, Seulgi Shin, Yoonsik Sung, Ha Eun Lee, Kyu Hyeon Kim, Ji Yeon Song, Gwan‐Ho Lee, Hira Aziz, Nataliia Lukianenko, Dong Min Kang et al. · 2023 · Experimental & Molecular Medicine
  40. Epigenetic Drug Discovery for Alzheimer’s Disease
    Ramón Cacabelos, Óscar Teijido · 2017 · Elsevier eBooks
  41. Targeting Autophagy, Apoptosis, and SIRT1/Nrf2 Axis with Topiramate Underlies Its Neuroprotective Effect against Cadmium-Evoked Cognitive Deficits in Rats
    Hany H. Arab, Ahmed H. Eid, Rania Yahia, Shuruq E. Alsufyani, Ahmed M. Ashour, Azza A. K. El‐Sheikh, Hany W. Darwish, Muhammed A. Saad, Muhammad Y. Al‐Shorbagy, Marwa Ashour Masoud · 2023 · Pharmaceuticals
  42. Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimer’s Disease-like Type
    Ryszard M. Pluta, Stanisław Jerzy Czuczwar · 2024 · International Journal of Molecular Sciences
  43. Can any “non-specific charge modification within microtubule binding domains of Tau” be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform
    Abolfazl Jangholi, Mohammad Reza Ashrafi-Kooshk, Seyed Shahriar Arab, Saeed Karima, Mansour Poorebrahim, Seyyed Abolghasem Ghadami, Ali Akbar Moosavi‐Movahedi, Reza Khodarahmi‬ · 2017 · International Journal of Biological Macromolecules
  44. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin
    Maria V. Barbolina · 2021 · Pharmacological Research
  45. JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1
    Jessica L. Dennison, Claude‐Henry Volmar, Farzaneh Modarresi, Danbing Ke, James Wang, Emilie Gravel, Sabrina Vignini-Hammond, Zuomei Li, James A. Timmons, Ines Lohse et al. · 2022 · Journal of Alzheimer s Disease
  46. The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease development
    Ravinder Jit Singh, Julfequar Hussain, Amandeep Kaur, Balaji Gokul Jamdare, Deepti Pathak, Kanchan Garg, Ramanpreet Kaur, Shivani Shankar, Aditya Sunkaria · 2023 · Ageing Research Reviews
  47. Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression
    Hye Jin Heo, So Youn Park, Yi Sle Lee, Hwa Kyoung Shin, Ki Whan Hong, Chi Dae Kim · 2020 · Korean Journal of Physiology and Pharmacology
  48. AMPK activators for the prevention and treatment of neurodegenerative diseases
    Natalie R. Neumann, David C. Thompson, Vasilis Vasiliou · 2021 · Expert Opinion on Drug Metabolism & Toxicology
  49. Tau in Alzheimer's disease: Shaping the future patient journey
    Catherine Jane Mummery, Christopher Chen Li-Hsian, Cristian A. Lasagna‐Reeves, Rik Ossenkoppele, Christopher C. Rowe, Douglas W. Scharre, Huali Wang, Simon Kyaga, Jeffrey L. Cummings · 2026 · The Journal of Prevention of Alzheimer s Disease
  50. Brd2 haploinsufficiency extends lifespan and healthspan in C57B6/J mice
    Shilpa Pathak, William C. L. Stewart, Christin Elizabeth Burd, Mark E. Hester, David A. Greenberg · 2020 · PLoS ONE
  51. Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges
    Chenxi He, Jinying Gu, Danni Wang, Keran Wang, Yuxuan Wang, Qidong You, Lei Wang · 2023 · European Journal of Medicinal Chemistry
  52. Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
    Moumita Majumder, Debashis Dutta · 2024 · Cells
  53. Dendrimers—Novel Therapeutic Approaches for Alzheimer’s Disease
    Mroziak, Magdalena, Kozłowski, Gracjan, Kołodziejczyk, Weronika, Pszczołowska, Magdalena, Walczak, Kamil, Beszłej, Jan Aleksander, Leszek, Jerzy · 2024 · Biomedicines
  54. Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
    Futao Zhou, Yushi Zhao, Yangyan Sun, Wanjiao Chen · 2024 · Journal of Integrative Neuroscience
  55. In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein
    Yong‐Chan Kim, Byung‐Hoon Jeong · 2019 · Current Alzheimer Research
  56. Acetylation of Aβ 40 Alters Aggregation in the Presence and Absence of Lipid Membranes
    Albert W. Pilkington, Jane E. Schupp, Morgan Nyman, Stephen J. Valentine, David M. Smith, Justin A. Legleiter · 2019 · ACS Chemical Neuroscience
  57. SRC3 acetylates calmodulin in the mouse brain to regulate synaptic plasticity and fear learning
    Hailong Zhang, Wei Han, Yin-Quan Du, Bing Tian Zhao, Pin Yang, Dong‐Min Yin · 2021 · Journal of Biological Chemistry
  58. Is SIRT6 Activity Neuroprotective and How Does It Differ from SIRT1 in This Regard?
    Bor Luen Tang · 2017 · Frontiers in Cellular Neuroscience
  59. Progress in the treatment of Parkinson-Plus syndromes
    Nahid Olfati, Ali Shoeibi, Irene Litvan · 2018 · Parkinsonism & Related Disorders
  60. Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
    Harish Kumar, Jayant B. Udgaonkar · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  61. Self-acetylation at the active site of phosphoenolpyruvate carboxykinase (PCK1) controls enzyme activity
    Pedro Latorre‐Muro, Josue Baeza, Ramón Hurtado‐Guerrero, Thomas Hicks, Ignacio Delso, Cristina Hernández-Ruiz, Adrián Velázquez‐Campoy, Alexis J. Lawton, Jesús Angulo, John M. Denu et al. · 2020 · Journal of Biological Chemistry
  62. Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools
    Isabelle Landrieu, Elian Dupré, Davy Sinnaeve, Léa El Hajjar, Caroline Smet‐Nocca · 2022 · Frontiers in Chemistry
  63. RETRACTED ARTICLE: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
    Mennatallah O. Zaki, S. El-Desouky, Doaa A. Elsherbiny, Mohamed Salama, Samar S. Azab · 2022 · Inflammopharmacology · Retracted
  64. Sirtuins, Healthspan, and Longevity in Mammals
    William Giblin, David B. Lombard · 2015 · Elsevier eBooks
  65. Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells
    Jun‐Fei Zhang, Zhi‐Ting Fang, Jun‐Ning Zhao, Gong‐Ping Liu, Xin Shen, Gaofeng Jiang, Qian Rong Liu · 2024 · Journal of Neurochemistry
  66. Deacetylase SIRT2 Inhibition Promotes Microglial M2 Polarization Through Axl/PI3K/AKT to Alleviate White Matter Injury After Subarachnoid Hemorrhage
    Kaikun Yuan, Qiaowei Wu, Yanting Yao, Jiang Shao, Shiyi Zhu, Jinshuo Yang, Qi Lun Sun, Junjie Zhao, Jiayi Xu, Pei Wu et al. · 2024 · Translational Stroke Research
  67. Autophagy Dysfunction and Neurodegeneration: Where Does It Go Wrong?
    Daphne Oettinger, Ai Yamamoto · 2025 · Journal of Molecular Biology
  68. Sirtuins and Neurodegeneration
    Gizem Dönmez · 2017 · Journal of Neurology and Neuromedicine
  69. Nicotinamide mononucleotide (NMN) and NMN-rich product supplementation alleviate p-chlorophenylalanine-induced sleep disorders
    Chunyan Shen, Xiaoyi Li, Pan-Yu Ma, Hong‐Lei Li, Bing Xiao, Wei‐Feng Cai, Xuefeng Xing · 2022 · Journal of Functional Foods
  70. The Fate of Tau Aggregates Between Clearance and Transmission
    Assel Seitkazina, Kyu Hyeon Kim, Erin Fagan, Yoonsik Sung, Yun Kyung Kim, Sungsu Lim · 2022 · Frontiers in Aging Neuroscience
  71. Development of tau-directed Small Molecule Modulators for Alzheimer’s Disease: a Recent Patent Review (2014–2018)
    Ha E Lee, Dami Lim, Jae Yeol Lee, Sang Min Lim, Ae Nim Pae · 2019 · Pharmaceutical Patent Analyst
  72. Human neuronal cells: epigenetic aspects
    Jessica Kukucka, Tessa Wyllie, Justin L. Read, Lauren Mahoney, Cenk Suphioglu · 2013 · BioMolecular Concepts
  73. CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease
    Rohan V. Gupta, Pravir Kumar · 2021 · ACS Omega
  74. Activation of the TREK-1 Potassium Channel Improved Cognitive Deficits in a Mouse Model of Alzheimer’s Disease by Modulating Glutamate Metabolism
    Fang Li, Shu-ning Zhou, Xin Zeng, Zhen Li, Rui Yang, Xuexi Wang, Bin Meng, Wei-lin Pei, Li Lu · 2022 · Molecular Neurobiology
  75. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling
    Syed Jawad Ali Shah, Qianqian Zhang, Jingjing Guo, Hongli Liu, Huanxiang Liu, Jordi Villà­-Freixa · 2023 · ACS Chemical Neuroscience
  76. Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease
    Menglu Liu, Shuaipeng Ma, Wenjiao Tai, Xiaoling Zhong, Haoqi Ni, Yuhua Zou, Jingcheng Wang, Chun‐Li Zhang · 2024 · Cell Death and Disease
  77. Caffeine improves mitochondrial dysfunction in the white matter of neonatal rats with hypoxia-ischemia through deacetylation: a proteomic analysis of lysine acetylation
    Yajun Zhang, Yuqian Wang, Haiping Dou, Shanshan Wang, Danyang Qu, Xin Peng, Ning Zou, Liu Yang · 2024 · Frontiers in Molecular Neuroscience
  78. Expression Levels of SMAD Specific E3 Ubiquitin Protein Ligase 2 (Smurf2) and its Interacting Partners Show Region-specific Alterations During Brain Aging
    Melek Umay Tuz-Sasik, Elif Tugce Karoglu-Eravsar, Meric Kinali, Ayca Arslan Ergul, Michelle M. Adams · 2020 · Neuroscience
  79. SIRT 1 binding with PKM and NSE and modulate their acetylation and activities
    Zhaohuan Zhang, Hui Zhang, Yuerong Wang, Xiu-ling Liu, Hai Huang, Xiaohui Xu · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  80. Succinylation Links Metabolic Reductions to Amyloid and Tau Pathology
    Yun Yang, Vı́ctor Tapias, Diana M. Acosta, Hui Xu, Huan‐Lian Chen, Ruchika P. Bhawal, Elizabeth Anderson, Elena Ivanova, Hening Lin, Botir T. Sagdullaev et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
    Mohammed M. Alhadidy, Nicholas M. Kanaan · 2024 · Biochemical Society Transactions
  82. Targeting tau in Alzheimer’s Disease: rationale, approach and challenges
    Aram Aslanyan, Martha S. Foiani, Tatiana A. Giovannucci, Eric McDade, Karen Duff, Catherine Jane Mummery, Michael Schöll, Kristin R. Wildsmith, Ross W. Paterson · 2026 · Molecular Neurodegeneration
  83. Brain-protective mechanisms of autophagy associated circRNAs: Kick starting self-cleaning mode in brain cells via circRNAs as a potential therapeutic approach for neurodegenerative diseases
    Rabea Basri, Faryal Mehwish Awan, Burton B. Yang, Usman Ayub Awan, Ayesha Obaid, Anam Naz, Aqsa Ikram, Suliman Khan, Ijaz ul Haq, Sadiq Noor Khan et al. · 2023 · Frontiers in Molecular Neuroscience
  84. Genetically Engineered Triple MAPT-Mutant Human-Induced Pluripotent Stem Cells (N279K, P301L, and E10+16 Mutations) Exhibit Impairments in Mitochondrial Bioenergetics and Dynamics
    Leonora Szabo, Amandine Grimm, Juan Antonio García‐León, Catherine M. Verfaillie, Anne Eckert · 2023 · Cells
  85. Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease
    Sachin V Kammula, Sulagna Tripathi, Ning Wang, Valina Lynn Dawson, Ted M. Dawson, Xiaobo Mao · 2023 · Ageing and Neurodegenerative Diseases
  86. Role of SIRT1 in Epigenetics
    Zhipeng A. Wang, Willie W. Hsu, Wenshe Ray Liu · 2019 · Springer eBooks
  87. Sirtuins in Brain and Neurodegenerative Disease
    Éva M. Szegő, Tiago F. Outeiro, Aleksey G. Kazantsev · 2018 · Elsevier eBooks
  88. The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers
    Chiara Argentati, Ilaria Tortorella, Martina Bazzucchi, Carla Emiliani, Francesco Morena, Sabata Martino · 2020 · Journal of Personalized Medicine
  89. Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment 171IPAKTPPAPK180 Using Molecular Dynamic Simulation and the Markov State Model
    Syed Jawad Ali Shah, Haiyang Zhong, Qianqian Zhang, Huanxiang Liu · 2022 · International Journal of Molecular Sciences
  90. Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer’s Disease
    Ryszard M. Pluta, Sławomir Januszewski, Mirosław Jabłoński · 2022 · International Journal of Molecular Sciences
  91. Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6
    J.D. Osko, David W. Christianson · 2020 · Acta Crystallographica Section F Structural Biology Communications
  92. Diverse influences on tau aggregation and implications for disease progression
    Meaghan Van Alstyne, James Pratt, Roy Parker · 2025 · Genes & Development
  93. Exploring the Role of Tau Proteins in Alzheimer’s Disease from Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain
    Gadde Shareena, Dileep Kumar · 2023 · Springer eBooks
  94. Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons
    Yoonah R. Oh, Min‐Kyoo Shin · 2025 · BMB Reports
  95. Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases
    Gamze Koçak, Mylla M. Dimas, Luiz Silva, Danyelle Silva-Amaral, Congxin Sun, Sophie Cruddas, Timothy Geoffrey Barrett, Daniel Martins‐de‐Souza, Edécio Cunha‐Neto, Patrícia S. Brocardo et al. · 2025 · Frontiers in Molecular Biosciences
  96. Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
    Allie N. Greene, Matia B. Solomon, Lisa M. Privette Vinnedge · 2022 · Frontiers in Aging Neuroscience
  97. Molecular Mechanisms of Emerging Therapeutic Targets in Alzheimer’s Disease: A Systematic Review
    T. Premkumar, Sajitha Lulu S · 2022 · Neurochemical Journal
  98. A Novel Class I HDAC Inhibitor, AW01178, Inhibits Epithelial–Mesenchymal Transition and Metastasis of Breast Cancer
    Xiangxiang Liu, Yawen Chen, Li Yang, Shen Ying, Shasha Dong, Jiang Tan · 2024 · International Journal of Molecular Sciences
  99. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease
    Miles R. Bryan, Xu Tian, Jui‐Heng Tseng, Baggio Evangelista, Joey V. Ragusa, Audra F. Bryan, Winifred Trotman, David John Irwin, Todd J. Cohen · 2024 · Acta Neuropathologica Communications
  100. A microdeletion in Alzheimer’s disease disrupts NAMPT gene
    Darine Villela, DAVID SCHLESINGER, Cláudia Kimie Suemoto, Lea T. Grinberg, Carla Rosenberg · 2014 · Journal of Genetics